BPA Call 75F40118A10047-75F40123F19021

Award Date 7/5/23
Potential Completion Date 6/30/24
Potential Value $1.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price BPA Call order awarded by the Food and Drug Administration (FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company. The purpose of this $1,928,972.27 contract is to allow the FDA to continue collecting user fees from industry and report on these fee collections efficiently and accurately. The contract has an ultimate completion date of March 31, 2024 and is...
This federal contract was awarded to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company, by the Department of Health and Human Services Food and Drug Administration (HHS FDA). The contract, valued at $474,341.84, provides support for the FDA's Unified Financial Management System (UFMS) G-Invoicing implementation, a key financial management system. Equinoxys Inc. has an extensive track...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company. The contract, valued at $403,094.39, is a Blanket Purchase Agreement (BPA) call order under the Multiple Award Schedule (MAS) contract vehicle. The contract is to provide support for the implementation of user...
This is a $1,646,482.02 firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business. The contract provides implementation support services for the HHS FDA's Unified Financial Management System (UFMS) modernization efforts. Services include transitioning systems to new platforms, integrating electronic invoicing, automating processes, and maintaining...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned IT services company. The contract, titled "UFMS SPECIAL PROJECT SUPPORT SERVICES (UFMS KNIME TOOL IMPLEMENTATION)", has a potential value of $229,952.72 and was awarded on a Labor Hours pricing type under the Multiple Award...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Equinoxys Inc., a Minority-Owned, Self-Certified Small Disadvantaged Business, and Subcontinent Asian-American Owned IT services and management consulting company. The $2,640,656.71 contract calls for Equinoxys to provide architecture, implementation, and maintenance services for the FDA's Financial Management System (FMS) user fee re-architecture and electronic invoicing...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a Blanket Purchase Agreement (BPA) call to Equinoxys Inc., a Minority Owned, Small Disadvantaged Business, to provide invoice processing platform (IPP) support services for the FDA's Unified Financial Management System (UFMS). The firm fixed-price contract, valued at $596,386.44, has a period of performance through January 31, 2024. Equinoxys Inc. will deliver operations and maintenance, system...
This is a delivery order contract awarded to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, by the Food and Drug Administration (FDA) under the Multiple Award Schedule (MAS) contract vehicle. The contract, valued at $17,026,367.11, is for Operations and Maintenance (O&M) technical support services for the FDA's Unified Financial Management System (UFMS) and User Fee systems. The contract has a period of performance through March 23, 2026. Equinoxys Inc....
The U.S. Food and Drug Administration (FDA) awarded a contract to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, for Unified Financial Management System (UFMS) cash management and accounting support services. The $1,296,382.52 Firm Fixed Price contract, awarded under the Information Technology Schedule 70 (IT-70) contract vehicle, has an ultimate completion date of September 23, 2023. Equinoxys Inc. is a key contractor for the FDA, providing a range of services to...
This firm-fixed-price BPA call was awarded to Equinoxys Inc., a minority-owned, self-certified small disadvantaged business, by the Food and Drug Administration (FDA) for $997,315.07. The contract is for data analytics implementation support services, including operations and maintenance, cloud migration, process automation, e-invoicing integration, and infrastructure upgrades for the agency's Unified Financial Management System (UFMS) and User Fee systems. Equinoxys has previously supported the...

This is a $1,671,906.19 BPA Call contract awarded by the Food and Drug Administration (FDA) to Equinoxys Inc., a Minority Owned Business, Self Certified Small Disadvantaged Business, and Subcontinent Asian (Asian-Indian) American Owned company. The contract is to support the FDA's Unified Financial Management System (UFMS) and User Fee systems through IT modernization, data analytics, and professional services. Key efforts include transitioning legacy systems, unearned funds tracking, refund process automation, budget management solutions, and development of portals and dashboards. Equinoxys Inc. has an extensive track record of delivering these types of services to the FDA and Department of the Treasury. The contract has a period of performance through June 30, 2024 and was not set aside.

Generated 6/28/24, 9:52 AM